Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease
| Published in: | Haematologica |
|---|---|
| Main Authors: | Satheesh Chonat, Maa-Ohui Quarmyne, Caroline M. Bennett, Christina L. Dean, Clinton H. Joiner, Ross M. Fasano, Sean R. Stowell |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2018-10-01
|
| Online Access: | https://haematologica.org/article/view/8644 |
Similar Items
Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
by: Satheesh Chonat, et al.
Published: (2020-07-01)
by: Satheesh Chonat, et al.
Published: (2020-07-01)
Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
by: Swee Lay Thein, et al.
Published: (2020-03-01)
by: Swee Lay Thein, et al.
Published: (2020-03-01)
Initiation and Regulation of Complement during Hemolytic Transfusion Reactions
by: Sean R. Stowell, et al.
Published: (2012-01-01)
by: Sean R. Stowell, et al.
Published: (2012-01-01)
Delayed hemolytic transfusion reaction in children with sickle cell disease
by: Mariane de Montalembert, et al.
Published: (2011-06-01)
by: Mariane de Montalembert, et al.
Published: (2011-06-01)
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease
by: F. Noizat-Pirenne, et al.
Published: (2007-12-01)
by: F. Noizat-Pirenne, et al.
Published: (2007-12-01)
Sickle Hyper-hemolytic Transfusion Reaction Syndrome
by: Neha Hurkat
Published: (2018-12-01)
by: Neha Hurkat
Published: (2018-12-01)
Delayed Hemolytic Transfusion Reaction in a Patient with Sickle Cell Disease: Case Report
by: Omer SA, et al.
Published: (2020-07-01)
by: Omer SA, et al.
Published: (2020-07-01)
Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease
by: Aline Floch, et al.
Published: (2020-07-01)
by: Aline Floch, et al.
Published: (2020-07-01)
Alloimmunization and consequential delayed hemolytic transfusion reactions in sickle cell disease patients: A case series
by: Tahsim Anwar, et al.
Published: (2025-07-01)
by: Tahsim Anwar, et al.
Published: (2025-07-01)
Two Consecutive Episodes of Severe Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient
by: Clarisse Mpinganzima, et al.
Published: (2020-01-01)
by: Clarisse Mpinganzima, et al.
Published: (2020-01-01)
Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France
by: Claire Falguière, et al.
Published: (2022-11-01)
by: Claire Falguière, et al.
Published: (2022-11-01)
Hemolytic disease of the newborn due to alloimmunization as a consequence of multiple transfusions and a delayed hemolytic transfusion reaction in the mother
by: T Kanra, et al.
Published: (1983-04-01)
by: T Kanra, et al.
Published: (1983-04-01)
CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion
by: Ryan P. Jajosky, et al.
Published: (2025-04-01)
by: Ryan P. Jajosky, et al.
Published: (2025-04-01)
Improving CORM technology for the treatment of delayed hemolytic transfusion reaction
by: Michela Asperti, et al.
Published: (2024-08-01)
by: Michela Asperti, et al.
Published: (2024-08-01)
Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions
by: Priyanka Pandey, et al.
Published: (2017-10-01)
by: Priyanka Pandey, et al.
Published: (2017-10-01)
Abnormal blood transfusion compatibility test results caused by delayed hemolytic reaction: a case report and transfusion strategy
by: Fang QIU, et al.
Published: (2024-03-01)
by: Fang QIU, et al.
Published: (2024-03-01)
A Case Report of Red Blood Cell Alloimmunization and Delayed Hemolytic Transfusion Reaction in a Patient with an Uncommon Phenotype in Sickle Cell Disease: Review of Diagnosis and Management
by: Cassandra P. Wang, et al.
Published: (2024-01-01)
by: Cassandra P. Wang, et al.
Published: (2024-01-01)
Changes in serum immunoglobulin levels in children with thalassemia who undergo repeated blood transfusions and their correlation with delayed hemolytic transfusion reactions
by: Xiaohong JIN, et al.
Published: (2024-05-01)
by: Xiaohong JIN, et al.
Published: (2024-05-01)
Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components
by: Jason Stevenson, et al.
Published: (2023-01-01)
by: Jason Stevenson, et al.
Published: (2023-01-01)
Identification of immune hemolytic transfusion reaction and exploration of transfusion compatibility testing
by: Xiujuan JIAO, et al.
Published: (2023-11-01)
by: Xiujuan JIAO, et al.
Published: (2023-11-01)
Investigation of Delayed Transfusion Reactions in Sickle Cell Disease Patients Polytransfused in the Brazilian Amazon
by: Lorena Alves Santos, et al.
Published: (2024-08-01)
by: Lorena Alves Santos, et al.
Published: (2024-08-01)
Ways to develop the prophylaxis of post-transfusion hemolytic complications
by: B. B. Bahovadinov, et al.
Published: (2015-12-01)
by: B. B. Bahovadinov, et al.
Published: (2015-12-01)
Hemolytic transfusion reaction analysis and domestic literature review
by: Xinxin HAO, et al.
Published: (2023-04-01)
by: Xinxin HAO, et al.
Published: (2023-04-01)
Incidental Discovery of Multiorgan Extramedullary Plasmacytomas in the Setting of Newly Diagnosed Multiple Myeloma and Delayed Hemolytic Transfusion Reaction
by: Joselle Cook, et al.
Published: (2017-01-01)
by: Joselle Cook, et al.
Published: (2017-01-01)
Sequential generation of anti-M and anti-Jka leads to two delayed hemolytic transfusion reactions and corresponding strategies
by: Honghui LONG, et al.
Published: (2024-05-01)
by: Honghui LONG, et al.
Published: (2024-05-01)
Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy
by: Elizabeth F. Stone, et al.
Published: (2020-08-01)
by: Elizabeth F. Stone, et al.
Published: (2020-08-01)
Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia
by: Eleni Gavriilaki, et al.
Published: (2018-10-01)
by: Eleni Gavriilaki, et al.
Published: (2018-10-01)
Severe, Refractory Primary Warm Autoimmune Hemolytic Anemia Requiring 90 Erythrocyte Transfusions
by: Neeharika Namineni, et al.
Published: (2024-05-01)
by: Neeharika Namineni, et al.
Published: (2024-05-01)
Masquerading of mismatched blood transfusion by underlying autoimmune hemolytic anemia
by: Priyanka Samal, et al.
Published: (2019-01-01)
by: Priyanka Samal, et al.
Published: (2019-01-01)
An Unusual Case of Hyperhemolysis Syndrome and Delayed Hemolytic Transfusion Reaction due to Anti-Jk(a) and Anti-P1 Antibodies
by: Hunter Montgomery, et al.
Published: (2023-01-01)
by: Hunter Montgomery, et al.
Published: (2023-01-01)
Serological characteristics of hemolytic transfusion reactions caused by Rh and Kidd antibodies
by: ZENG Qunjuan, et al.
Published: (2025-04-01)
by: ZENG Qunjuan, et al.
Published: (2025-04-01)
The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome
by: Piotr P. Avdonin, et al.
Published: (2023-12-01)
by: Piotr P. Avdonin, et al.
Published: (2023-12-01)
A Rare Case: Improved Heart Failure with Anti-Complement Therapy in Complement-Dependent Hemolytic Uremic Syndrome
by: Hakan Özer, et al.
Published: (2023-01-01)
by: Hakan Özer, et al.
Published: (2023-01-01)
Coexistent sickle cell anemia and autoimmune hemolytic anemia in two adolescents
by: Vinícius Reis Soares, et al.
Published: (2024-11-01)
by: Vinícius Reis Soares, et al.
Published: (2024-11-01)
S299: ROLE OF RED BLOOD CELL MEMBRANE-DERIVED PARTICLES ON ENDOTHELIAL DAMAGES DURING ONSET STAGE OF DELAYED HEMOLYTIC TRANSFUSION REACTION
by: N.-P. Kim-Anh, et al.
Published: (2022-06-01)
by: N.-P. Kim-Anh, et al.
Published: (2022-06-01)
Patterns of Blood Transfusion in Sickle Cell Disease Hospitalizations
by: Aditi Sharma, et al.
Published: (2024-01-01)
by: Aditi Sharma, et al.
Published: (2024-01-01)
Red cell transfusion and alloimmunization in sickle cell disease
by: Grace E. Linder, et al.
Published: (2021-04-01)
by: Grace E. Linder, et al.
Published: (2021-04-01)
Best practices for transfusion for patients with sickle cell disease
by: Ted Wun, et al.
Published: (2010-01-01)
by: Ted Wun, et al.
Published: (2010-01-01)
Blood-storage duration affects hematological and metabolic profiles in patients with sickle cell disease receiving transfusions
by: Matthew S. Karafin, et al.
Published: (2025-09-01)
by: Matthew S. Karafin, et al.
Published: (2025-09-01)
Isoimmunization and hemolytic transfusion reaction due to anti-c and anti-Jk combination
by: T Kanra, et al.
Published: (1977-01-01)
by: T Kanra, et al.
Published: (1977-01-01)
Similar Items
-
Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
by: Satheesh Chonat, et al.
Published: (2020-07-01) -
Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
by: Swee Lay Thein, et al.
Published: (2020-03-01) -
Initiation and Regulation of Complement during Hemolytic Transfusion Reactions
by: Sean R. Stowell, et al.
Published: (2012-01-01) -
Delayed hemolytic transfusion reaction in children with sickle cell disease
by: Mariane de Montalembert, et al.
Published: (2011-06-01) -
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease
by: F. Noizat-Pirenne, et al.
Published: (2007-12-01)
